Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 62

1.

Rheumatologists use different cut offs for disease activity in real life - the experience with Golimumab in ankylosing spondylitis - Subanalysis from the Non-Interventional German GO-NICE study.

Braun J, Baraliakos X, Kiltz U, Krüger K, Burmester GR, Wassenberg S, Thomas MH.

J Rheumatol. 2019 Mar 15. pii: jrheum.181040. doi: 10.3899/jrheum.181040. [Epub ahead of print]

2.

Patient-reported outcomes with golimumab in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: non-interventional study GO-NICE in Germany.

Krüger K, Burmester GR, Wassenberg S, Bohl-Bühler M, Thomas MH.

Rheumatol Int. 2019 Jan;39(1):131-140. doi: 10.1007/s00296-018-4180-4. Epub 2018 Nov 10.

3.

[S2e guideline: treatment of rheumatoid arthritis with disease-modifying drugs].

Fiehn C, Holle J, Iking-Konert C, Leipe J, Weseloh C, Frerix M, Alten R, Behrens F, Baerwald C, Braun J, Burkhardt H, Burmester G, Detert J, Gaubitz M, Gause A, Gromnica-Ihle E, Kellner H, Krause A, Kuipers J, Lorenz HM, Müller-Ladner U, Nothacker M, Nüsslein H, Rubbert-Roth A, Schneider M, Schulze-Koops H, Seitz S, Sitter H, Specker C, Tony HP, Wassenberg S, Wollenhaupt J, Krüger K.

Z Rheumatol. 2018 Aug;77(Suppl 2):35-53. doi: 10.1007/s00393-018-0481-y. Review. German.

PMID:
29968101
4.
5.

Erratum to: Impact of Participation in the Adalimumab (Humira) Patient Support Program on Rheumatoid Arthritis Treatment Course: Results from the PASSION Study.

Van den Bosch F, Ostor AJK, Wassenberg S, Chen N, Wang C, Garg V, Kalabic J.

Rheumatol Ther. 2017 Jun;4(1):97. doi: 10.1007/s40744-017-0065-3. No abstract available.

6.

Impact of Participation in the Adalimumab (Humira) Patient Support Program on Rheumatoid Arthritis Treatment Course: Results from the PASSION Study.

Van den Bosch F, Ostor AJK, Wassenberg S, Chen N, Wang C, Garg V, Kalabic J.

Rheumatol Ther. 2017 Jun;4(1):85-96. doi: 10.1007/s40744-017-0061-7. Epub 2017 Mar 30. Erratum in: Rheumatol Ther. 2017 Jun;4(1):97.

7.

Response to methotrexate predicts long-term mortality of patients with rheumatoid arthritis independent of the degree of response: results of a re-evaluation 30 years after baseline.

Krause C, Herborn G, Braun J, Rudolf H, Wassenberg S, Rau R, Krause D.

Clin Exp Rheumatol. 2017 May-Jun;35(3):384-389. Epub 2016 Dec 13.

PMID:
27974101
8.

[Standards of care for people with rheumatoid arthritis in Europe : Translation and comments of the eumusc.net recommendations supported by EULAR performed by a national task force of the professional organisations DGRh and VRA supported by "Deutsche Rheumaliga"].

Braun J, Krause A, Aringer M, Burmester G, Bessler F, Engel JM, Faubel U, Fischer-Betz R, Genth E, Gromnica-Ihle E, Hellmich B, Kötter I, Krüger K, Lakomek J, Lorenz HM, Manger B, Märker-Hermann E, Minden K, Müller-Ladner U, Rautenstrauch J, Rehart S, Riemekasten G, Rudwaleit M, Rüther W, Schett G, Schuch F, Schulze-Koops H, Specker C, Wassenberg S, Wiek D, Zink A, Schneider M.

Z Rheumatol. 2016 May;75(4):416-28. doi: 10.1007/s00393-016-0059-5. German.

PMID:
27138788
9.

[Do we still need clinical studies in rheumatology?].

Henkemeier U, Alten R, Bannert B, Baraliakos X, Behrens F, Heldmann F, Kiltz U, Köhm M, König R, Leipe J, Müller-Ladner U, Rech J, Riechers E, Rubbert-Roth A, Schmidt RE, Schulze-Koops H, Specker C, Tausche AK, Wassenberg S, Witt M, Witte T, Zernicke J, Burkhardt H.

Z Rheumatol. 2016 Feb;75(1):4-10. doi: 10.1007/s00393-015-1687-x. German.

PMID:
26680367
10.

Trends in treatment and outcomes of ankylosing spondylitis in outpatient rheumatological care in Germany between 2000 and 2012.

Huscher D, Thiele K, Rudwaleit M, Albrecht KC, Bischoff S, Krause A, Karberg K, Wassenberg S, Zink A.

RMD Open. 2015 May 25;1(1):e000033. doi: 10.1136/rmdopen-2014-000033. eCollection 2015.

11.

Radiographic scoring methods in psoriatic arthritis.

Wassenberg S.

Clin Exp Rheumatol. 2015 Sep-Oct;33(5 Suppl 93):S55-9. Epub 2015 Oct 15. Review.

PMID:
26472605
12.

Comparison of tocilizumab and tumour necrosis factor inhibitors in rheumatoid arthritis: a retrospective analysis of 1603 patients managed in routine clinical practice.

Backhaus M, Kaufmann J, Richter C, Wassenberg S, Roske AE, Hellmann P, Gaubitz M.

Clin Rheumatol. 2015 Apr;34(4):673-81. doi: 10.1007/s10067-015-2879-0. Epub 2015 Jan 29.

13.

Hydroxychloroquine in patients with inflammatory and erosive osteoarthritis of the hands (OA TREAT): study protocol for a randomized controlled trial.

Detert J, Klaus P, Listing J, Höhne-Zimmer V, Braun T, Wassenberg S, Rau R, Buttgereit F, Burmester GR.

Trials. 2014 Oct 27;15:412. doi: 10.1186/1745-6215-15-412.

14.

Rituximab in patients with rheumatoid arthritis in routine practice (GERINIS): six-year results from a prospective, multicentre, non-interventional study in 2,484 patients.

Wendler J, Burmester GR, Sörensen H, Krause A, Richter C, Tony HP, Rubbert-Roth A, Bartz-Bazzanella P, Wassenberg S, Haug-Rost I, Dörner T.

Arthritis Res Ther. 2014 Mar 26;16(2):R80. doi: 10.1186/ar4521.

15.

Clinical outcomes and safety of rituximab treatment for patients with systemic lupus erythematosus (SLE) - results from a nationwide cohort in Germany (GRAID).

Witt M, Grunke M, Proft F, Baeuerle M, Aringer M, Burmester G, Chehab G, Fiehn C, Fischer-Betz R, Fleck M, Freivogel K, Haubitz M, Kötter I, Lovric S, Metzler C, Rubberth-Roth A, Schwarting A, Specker C, Tony HP, Unger L, Wassenberg S, Dörner T, Schulze-Koops H; German Registry of Autoimmune Diseases (GRAID) Investigators.

Lupus. 2013 Oct;22(11):1142-9. doi: 10.1177/0961203313503912.

PMID:
24057058
16.

German guidelines for the sequential medical treatment of rheumatoid arthritis with traditional and biologic disease-modifying antirheumatic drugs.

Albrecht K, Krüger K, Wollenhaupt J, Alten R, Backhaus M, Baerwald C, Bolten W, Braun J, Burkhardt H, Burmester GR, Gaubitz M, Gause A, Gromnica-Ihle E, Kellner H, Kuipers J, Krause A, Lorenz HM, Manger B, Nüßlein H, Pott HG, Rubbert-Roth A, Schneider M, Specker C, Schulze-Koops H, Tony HP, Wassenberg S, Müller-Ladner U; German Society of Rheumatology.

Rheumatol Int. 2014 Jan;34(1):1-9. doi: 10.1007/s00296-013-2848-3. Epub 2013 Aug 14. Review.

PMID:
23942828
17.

Improved radiological outcome of rheumatoid arthritis: the importance of early treatment with methotrexate in the era of biological drugs.

Fiehn C, Belke-Voss E, Krause D, Wassenberg S, Rau R.

Clin Rheumatol. 2013 Dec;32(12):1735-42. doi: 10.1007/s10067-013-2325-0. Epub 2013 Aug 8.

PMID:
23925553
18.

[German 2012 guidelines for the sequential medical treatment of rheumatoid arthritis. Adapted EULAR recommendations and updated treatment algorithm].

Krüger K, Wollenhaupt J, Albrecht K, Alten R, Backhaus M, Baerwald C, Bolten W, Braun J, Burkhardt H, Burmester G, Gaubitz M, Gause A, Gromnica-Ihle E, Kellner H, Kuipers J, Krause A, Lorenz HM, Manger B, Nüßlein H, Pott HG, Rubbert-Roth A, Schneider M, Specker C, Schulze-Koops H, Tony HP, Wassenberg S, Müller-Ladner U; European League of Associations for Rheumatology (EULAR).

Z Rheumatol. 2012 Sep;71(7):592-603. doi: 10.1007/s00393-012-1038-0. German.

PMID:
22930110
19.

Induction therapy with adalimumab plus methotrexate for 24 weeks followed by methotrexate monotherapy up to week 48 versus methotrexate therapy alone for DMARD-naive patients with early rheumatoid arthritis: HIT HARD, an investigator-initiated study.

Detert J, Bastian H, Listing J, Weiß A, Wassenberg S, Liebhaber A, Rockwitz K, Alten R, Krüger K, Rau R, Simon C, Gremmelsbacher E, Braun T, Marsmann B, Höhne-Zimmer V, Egerer K, Buttgereit F, Burmester GR.

Ann Rheum Dis. 2013 Jun;72(6):844-50. doi: 10.1136/annrheumdis-2012-201612. Epub 2012 Jun 27.

PMID:
22739990
20.

A dose of only 5 mg prednisolone daily retards radiographic progression in early rheumatoid arthritis - the Low-Dose Prednisolone Trial.

Wassenberg S, Rau R, Zeidler H; Low-Dose Prednisolone Trail Group.

Clin Exp Rheumatol. 2011 Sep-Oct;29(5 Suppl 68):S68-72. Epub 2011 Oct 21.

PMID:
22018187
21.

[For parenteral gold therapy in rheumatoid arthritis].

Wassenberg S.

Dtsch Med Wochenschr. 2011 Aug;136(33):1676. doi: 10.1055/s-0031-1281575. Epub 2011 Aug 10. Review. German. No abstract available.

PMID:
21833891
22.

Impact of patient and disease characteristics on therapeutic success during adalimumab treatment of patients with rheumatoid arthritis: data from a German noninterventional observational study.

Kleinert S, Tony HP, Krause A, Feuchtenberger M, Wassenberg S, Richter C, Röther E, Spieler W, Gnann H, Wittig BM.

Rheumatol Int. 2012 Sep;32(9):2759-67. doi: 10.1007/s00296-011-2033-5. Epub 2011 Aug 6.

23.

Safety and clinical outcomes of rituximab therapy in patients with different autoimmune diseases: experience from a national registry (GRAID).

Tony HP, Burmester G, Schulze-Koops H, Grunke M, Henes J, Kötter I, Haas J, Unger L, Lovric S, Haubitz M, Fischer-Betz R, Chehab G, Rubbert-Roth A, Specker C, Weinerth J, Holle J, Müller-Ladner U, König R, Fiehn C, Burgwinkel P, Budde K, Sörensen H, Meurer M, Aringer M, Kieseier B, Erfurt-Berge C, Sticherling M, Veelken R, Ziemann U, Strutz F, von Wussow P, Meier FM, Hunzelmann N, Schmidt E, Bergner R, Schwarting A, Eming R, Hertl M, Stadler R, Schwarz-Eywill M, Wassenberg S, Fleck M, Metzler C, Zettl U, Westphal J, Heitmann S, Herzog AL, Wiendl H, Jakob W, Schmidt E, Freivogel K, Dörner T; GRAID investigators.

Arthritis Res Ther. 2011 May 13;13(3):R75. doi: 10.1186/ar3337.

24.

Effect of rituximab on physical function and quality of life in patients with rheumatoid arthritis previously untreated with methotrexate.

Rigby W, Ferraccioli G, Greenwald M, Zazueta-Montiel B, Fleischmann R, Wassenberg S, Ogale S, Armstrong G, Jahreis A, Burke L, Mela C, Chen A.

Arthritis Care Res (Hoboken). 2011 May;63(5):711-20. doi: 10.1002/acr.20419.

25.

[Patient/rheumatologist evaluation of infusion treatment for rheumatoid arthritis].

Willeke P, Becker H, Wassenberg S, Pavenstädt H, Jacobi AM.

Z Rheumatol. 2011 Apr;70(3):232-4, 236-8. doi: 10.1007/s00393-011-0752-3. German.

PMID:
21359555
26.

Trends in treatment and outcomes of rheumatoid arthritis in Germany 1997-2007: results from the National Database of the German Collaborative Arthritis Centres.

Ziegler S, Huscher D, Karberg K, Krause A, Wassenberg S, Zink A.

Ann Rheum Dis. 2010 Oct;69(10):1803-8. doi: 10.1136/ard.2009.122101. Epub 2010 May 6. Erratum in: Ann Rheum Dis. 2011 Feb;70(2):398.

PMID:
20447953
27.

[On the occasion of the 75th birthday of Prof. Dr. med. Rolf Rau].

Wassenberg S.

Z Rheumatol. 2008 Nov;67(7):617-8. doi: 10.1007/s00393-008-0382-6. German. No abstract available.

PMID:
18956204
28.

The human anti-IL-1 beta monoclonal antibody ACZ885 is effective in joint inflammation models in mice and in a proof-of-concept study in patients with rheumatoid arthritis.

Alten R, Gram H, Joosten LA, van den Berg WB, Sieper J, Wassenberg S, Burmester G, van Riel P, Diaz-Lorente M, Bruin GJ, Woodworth TG, Rordorf C, Batard Y, Wright AM, Jung T.

Arthritis Res Ther. 2008;10(3):R67. doi: 10.1186/ar2438. Epub 2008 Jun 5.

29.

Two-year efficacy and safety of infliximab treatment in patients with active psoriatic arthritis: findings of the Infliximab Multinational Psoriatic Arthritis Controlled Trial (IMPACT).

Antoni CE, Kavanaugh A, van der Heijde D, Beutler A, Keenan G, Zhou B, Kirkham B, Tutuncu Z, Burmester GR, Schneider U, Furst DE, Molitor J, Keystone E, Gladman DD, Manger B, Wassenberg S, Weier R, Wallace DJ, Weisman MH, Kalden JR, Smolen JS.

J Rheumatol. 2008 May;35(5):869-76. Epub 2008 Mar 15.

PMID:
18381786
30.

Does tumor necrosis factor alpha inhibition promote or prevent heart failure in patients with rheumatoid arthritis?

Listing J, Strangfeld A, Kekow J, Schneider M, Kapelle A, Wassenberg S, Zink A.

Arthritis Rheum. 2008 Mar;58(3):667-77. doi: 10.1002/art.23281.

31.

Expert agreement confirms that negative changes in hand and foot radiographs are a surrogate for repair in patients with rheumatoid arthritis.

van der Heijde D, Landewé R, Boonen A, Einstein S, Herborn G, Rau R, Wassenberg S, Weissman BN, Winalski CS, Sharp JT.

Arthritis Res Ther. 2007;9(4):R62.

32.

Effectiveness of tumor necrosis factor inhibitors in rheumatoid arthritis in an observational cohort study: comparison of patients according to their eligibility for major randomized clinical trials.

Zink A, Strangfeld A, Schneider M, Herzer P, Hierse F, Stoyanova-Scholz M, Wassenberg S, Kapelle A, Listing J.

Arthritis Rheum. 2006 Nov;54(11):3399-407.

33.

[Outcome parameters for use in psoriatic arthritis].

Braun J, Wassenberg S.

Z Rheumatol. 2006 Mar;65(2):110, 112-8, 120-3. Review. German.

PMID:
16501924
34.

The Infliximab Multinational Psoriatic Arthritis Controlled Trial (IMPACT): results of radiographic analyses after 1 year.

Kavanaugh A, Antoni CE, Gladman D, Wassenberg S, Zhou B, Beutler A, Keenan G, Burmester G, Furst DE, Weisman MH, Kalden JR, Smolen J, van der Heijde D.

Ann Rheum Dis. 2006 Aug;65(8):1038-43. Epub 2006 Jan 26.

35.

Healthcare and burden of disease in psoriatic arthritis. A comparison with rheumatoid arthritis and ankylosing spondylitis.

Zink A, Thiele K, Huscher D, Listing J, Sieper J, Krause A, Gromnica-Ihle E, von Hinueber U, Wassenberg S, Genth E, Schneider M; German Collaborative Arthritis Centres.

J Rheumatol. 2006 Jan;33(1):86-90.

PMID:
16395755
37.

[Imaging techniques in rheumatology: conventional radiography in rheumatoid arthritis].

Rau R, Lingg G, Wassenberg S, Schorn C, Scherer A; Kommission "Bildgebende Verfahren" der Deutschen Gesellschaft für Rheumatologie.

Z Rheumatol. 2005 Oct;64(7):473-87. Review. German.

PMID:
16244831
38.

Reliability of scoring methods to measure radiographic change in patients with rheumatoid arthritis.

Rau R, Wassenberg S.

J Rheumatol. 2005 May;32(5):766-8. Review. No abstract available.

PMID:
15868606
39.

Sustained benefits of infliximab therapy for dermatologic and articular manifestations of psoriatic arthritis: results from the infliximab multinational psoriatic arthritis controlled trial (IMPACT).

Antoni CE, Kavanaugh A, Kirkham B, Tutuncu Z, Burmester GR, Schneider U, Furst DE, Molitor J, Keystone E, Gladman D, Manger B, Wassenberg S, Weier R, Wallace DJ, Weisman MH, Kalden JR, Smolen J.

Arthritis Rheum. 2005 Apr;52(4):1227-36. Erratum in: Arthritis Rheum. 2005 Sep;52(9):2951.

40.

Psoriatic arthritis imaging: a review of scoring methods.

van der Heijde D, Sharp J, Wassenberg S, Gladman DD.

Ann Rheum Dis. 2005 Mar;64 Suppl 2:ii61-4. Review.

41.

Treatment continuation in patients receiving biological agents or conventional DMARD therapy.

Zink A, Listing J, Kary S, Ramlau P, Stoyanova-Scholz M, Babinsky K, von Hinueber U, Gromnica-Ihle E, Wassenberg S, Antoni C, Herzer P, Kekow J, Schneider M, Rau R.

Ann Rheum Dis. 2005 Sep;64(9):1274-9. Epub 2005 Feb 11.

42.

Healing of erosive changes in rheumatoid arthritis.

Rau R, Herborn G, Wassenberg S.

Clin Exp Rheumatol. 2004 Sep-Oct;22(5 Suppl 35):S44-9. Review.

PMID:
15552514
43.

[Imaging techniques in rheumatology: scoring methods in rheumatoid arthritis].

Rau R, Wassenberg S.

Z Rheumatol. 2003 Dec;62(6):555-65. Review. German.

PMID:
14685718
44.

Methotrexate, hydroxychloroquine, and intramuscular gold in rheumatoid arthritis.

Wassenberg S, Rau R.

J Rheumatol. 2003 Aug;30(8):1891; author reply 1891-2. No abstract available.

PMID:
12913889
45.

Erosion healing in rheumatoid arthritis after anakinra treatment.

Rau R, Sander O, Wassenberg S.

Ann Rheum Dis. 2003 Jul;62(7):671-3. No abstract available.

46.

Repair of erosions in rheumatoid arthritis does occur. Results from 2 studies by the OMERACT Subcommittee on Healing of Erosions.

Sharp JT, Van Der Heijde D, Boers M, Boonen A, Bruynesteyn K, Emery P, Genant HK, Herborn G, Jurik A, Lassere M, McQueen F, Østergaard M, Peterfy C, Rau R, Strand V, Wassenberg S, Weissman B; Subcommittee on Healing of Erosions of the OMERACT Imaging Committee.

J Rheumatol. 2003 May;30(5):1102-7.

PMID:
12734916
47.
48.

[Early diagnosis of chronic polyarthritis with conventional roentgen imaging].

Wassenberg S.

Z Rheumatol. 2002 Apr;61(2):110-9. Review. German.

PMID:
12056288
49.

[Parallel occurrence of Paget disease and Bechterew disease].

Klink C, Hübner G, Wassenberg S.

Z Rheumatol. 2002 Feb;61(1):62-3. German. No abstract available.

PMID:
11974494
50.

Scoring methods.

Rau R, Wassenberg S.

J Rheumatol. 2002 Apr;29(4):653-5. Review. No abstract available.

PMID:
11950002

Supplemental Content

Loading ...
Support Center